Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Neuroradiol ; 50(5): 511-517, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36781119

RESUMO

BACKGROUND AND PURPOSE: Intracranial aneurysms are frequent in patients with sickle cell anemia, while subarachnoid hemorrhage is a major cause of death and disability in young adult patients. Several characteristics, such as younger age and smaller size at rupture, may incline therapeutic decision towards exclusion treatments. Clinical guidelines on treatment of unruptured intracranial aneurysms in this population are still missing. We aimed to assess the safety and efficacy of the treatment of unruptured intracranial aneurysm in patients with sickle cell anemia, using an adapted hematological preparation regimen. PATIENTS AND METHODS: Adult patients with sickle cell anemia and treated unruptured aneurysms by endovascular therapy or neurosurgery were included in this retrospective cohort study. Treatment decision was reached after multi-disciplinary assessment. A pre-operative blood transfusion protocol was undertaken targeting a HbS below 30%. Demographic data, hematological preparation parameters and clinical and radiological outcomes were documented. RESULTS AND CONCLUSIONS: Twenty-five procedures were performed in 18 patients encompassing 19 aneurysms treated by embolization and 6 by surgery. Median age at treatment was 34 years-old and median aneurysm dome size was 4.4 mm. Immediate aneurysm exclusion rate was 85.7% after endovascular therapy and 100% after neurosurgery. Median follow-up was 6 months, with all patients being asymptomatic at last follow-up. Two transitory ischemic neurological deficits, as well as four cases of iodine-induced encephalopathy were identified after embolization. No complication occurred after surgery. Endovascular therapy by coiling and neurosurgical treatment of unruptured intracranial aneurysms appears to be safe in patients with sickle cell anemia and should be considered given the specific hemorrhagic risk observed in this population. A rigorous hematological preparation, associated with a dedicated peri­operative protocol and an adequate therapeutic strategy are essential prerequisites.


Assuntos
Anemia Falciforme , Aneurisma Roto , Embolização Terapêutica , Procedimentos Endovasculares , Aneurisma Intracraniano , Adulto Jovem , Humanos , Adulto , Estudos de Coortes , Aneurisma Intracraniano/complicações , Aneurisma Intracraniano/diagnóstico por imagem , Aneurisma Intracraniano/terapia , Estudos Retrospectivos , Resultado do Tratamento , Procedimentos Endovasculares/métodos , Embolização Terapêutica/métodos , Anemia Falciforme/complicações , Anemia Falciforme/terapia , Aneurisma Roto/cirurgia
2.
Phys Rev B Condens Matter ; 33(7): 4758-4761, 1986 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9938940
3.
Phys Rev B Condens Matter ; 33(7): 5145-5148, 1986 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9939010
4.
Phys Rev B Condens Matter ; 35(7): 3675-3678, 1987 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9941883
5.
Phys Rev B Condens Matter ; 36(7): 3965, 1987 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-9943352
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA